K. Nirantharakumar

First name
Last name
Haroon, S., Nirantharakumar, K., Hughes, S. E., Subramanian, A., Aiyegbusi, O. L., Davies, E. H., et al. (2022). Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study). Bmj Open, 12, e060413. http://doi.org/10.1136/bmjopen-2021-060413
Lee, S. I., Azcoaga-Lorenzo, A., Agrawal, U., Kennedy, J. I., Fagbamigbe, A. F., Hope, H., et al. (2022). Epidemiology of pre-existing multimorbidity in pregnant women in the UK in 2018: a population-based cross-sectional study. Bmc Pregnancy Childbirth, 22, 120. http://doi.org/10.1186/s12884-022-04442-3
Sumilo, D., Nirantharakumar, K., Willis, B. H., Rudge, G., Martin, J., Gokhale, K., et al. (2019). Long-term impact of giving antibiotics before skin incision versus after cord clamping on children born by caesarean section: protocol for a longitudinal study based on UK electronic health records. BMJ Open. http://doi.org/10.1136/bmjopen-2019-033013
Rouette, J., Yin, H., Pottegard, A., Nirantharakumar, K., & Azoulay, L. (2020). Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer. Drug Saf. http://doi.org/10.1007/s40264-020-01015-1
Torlinska, B., Hazlehurst, J. M., Nirantharakumar, K., Thomas, G. N., Priestley, J. R., Finnikin, S. J., et al. (2021). wEight chanGes, caRdio-mEtabolic risks and morTality in patients with hyperthyroidism (EGRET): a protocol for a CPRD-HES linked cohort study. BMJ Open. http://doi.org/10.1136/bmjopen-2021-055219